Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • JASN Podcasts
    • Article Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Editorial Fellowship
    • Editorial Fellowship Team
    • Editorial Fellowship Application Process
  • More
    • About JASN
    • Advertising
    • Alerts
    • Feedback
    • Impact Factor
    • Reprints
    • Subscriptions
  • ASN Kidney News
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • JASN Podcasts
    • Article Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Editorial Fellowship
    • Editorial Fellowship Team
    • Editorial Fellowship Application Process
  • More
    • About JASN
    • Advertising
    • Alerts
    • Feedback
    • Impact Factor
    • Reprints
    • Subscriptions
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
Letters to the Editor
Open Access

Authors' Reply

Candice L. Clarke, Maria Prendecki, Stephen P. McAdoo and Michelle Willicombe
JASN December 2020, 31 (12) 2968; DOI: https://doi.org/10.1681/ASN.2020091276
Candice L. Clarke
1Department of Immunology and Inflammation, Centre for Inflammatory Disease, Imperial College London, London, United Kingdom
2Imperial College Renal and Transplant Centre, Imperial College Healthcare National Health Service Trust, Hammersmith Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Prendecki
1Department of Immunology and Inflammation, Centre for Inflammatory Disease, Imperial College London, London, United Kingdom
2Imperial College Renal and Transplant Centre, Imperial College Healthcare National Health Service Trust, Hammersmith Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen P. McAdoo
1Department of Immunology and Inflammation, Centre for Inflammatory Disease, Imperial College London, London, United Kingdom
2Imperial College Renal and Transplant Centre, Imperial College Healthcare National Health Service Trust, Hammersmith Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michelle Willicombe
1Department of Immunology and Inflammation, Centre for Inflammatory Disease, Imperial College London, London, United Kingdom
2Imperial College Renal and Transplant Centre, Imperial College Healthcare National Health Service Trust, Hammersmith Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michelle Willicombe
  • Article
  • Info & Metrics
  • View PDF
Loading
  • Seroprevalence
  • COVID-19

We agree with Rodríguez-Espinosa et al.1 that earlier and stricter use of personal protective equipment by patients within the dialysis units may have reduced the high prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection within our center. Specific discussion around the risk of transmission within our center’s individual dialysis units has been addressed in an earlier article by Corbett et al.2 We would, however, like to highlight that even with utilization of the same SARS-CoV-2 screening and management protocol, we have found a significant difference in prevalence rates between dialysis units within our center, which suggests a more complex relationship between infection rates in the community, patient characteristics, and clinical protocols.

We concur with the statement that regular screening of asymptomatic patients by RT-PCR testing would have detected more cases; however, it is also worth noting that false-negative results may occur even in symptomatic patients.3 The benefit of RT-PCR testing in asymptomatic patients is not known, but such practice does rely on a substantial resource investment, which may not be available at the time of infection surges. We agree that waiting for patients to become RT-PCR negative prior to deisolation may be a good practice. However, an ongoing challenge for the renal community is how to differentiate between viral RNA detection and infectivity.4 Patients may have prolonged carrier status, and there is a risk, especially in patients receiving in-center hemodialysis, that isolation facilities may become overburdened.

Related to our serologic study, as advances are made in the serologic testing for SARS-CoV-2, we believe that it is important to consider the type of assay, Ig isotype, and the target antigen being used to quantify seroprevalence.5 Rodríguez-Espinosa et al.1 do not provide the details of the assay they used to define seroprevalence within their unit, and it maybe that the differences between the two cohorts are even greater. We do believe that serologic methods need to be uniform in order to compare more accurately seroprevalence in different populations.

Disclosures

S. McAdoo reports Consultancy Agreements from GSK and Honoraria from Rigel Pharmaceuticals, ThermoFisher Scientific, and Celltrion. M. Willicombe reports Research Funding from Chiesi Pharmaceuticals. All remaining authors have nothing to disclose.

Funding

None.

Footnotes

  • Published online ahead of print. Publication date available at www.jasn.org.

  • See related Letters to the Editor, “Prevalence of COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening,” on pages 2966–2967.

  • Copyright © 2020 by the American Society of Nephrology

References

  1. ↵
    1. Rodríguez-Espinosa D,
    2. Broseta JJ,
    3. Cuadrado E,
    4. Maduell F
    : Prevalence of COVID-19 infection in hemodialysis patients detected using serologic screening. J Am Soc Nephrol 31: 2966–2967, 2020
    OpenUrlFREE Full Text
  2. ↵
    1. Corbett RW,
    2. Blakey S,
    3. Nitsch D,
    4. Loucaidou M,
    5. McLean A,
    6. Duncan N, et al.: West London Renal and Transplant Centre
    : Epidemiology of COVID-19 in an urban dialysis center. J Am Soc Nephrol 31: 1815–1823, 2020 pmid:32561681
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Clarke C,
    2. Prendecki M,
    3. Dhutia A,
    4. Ali MA,
    5. Sajjad H,
    6. Shivakumar O, et al
    .: High prevalence of asymptomatic COVID-19 infection in hemodialysis patients detected using serologic screening. J Am Soc Nephrol 31: 1969–1975, 2020 pmid:32732391
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Atkinson B,
    2. Petersen E
    : SARS-CoV-2 shedding and infectivity. Lancet 395: 1339–1340, 2020 pmid:32304647
    OpenUrlCrossRefPubMed
  5. ↵
    1. Kellam P,
    2. Barclay W
    : The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection. J Gen Virol 101: 791–797, 2020 pmid:32430094
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Journal of the American Society of Nephrology: 31 (12)
Journal of the American Society of Nephrology
Vol. 31, Issue 12
December 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
Authors' Reply
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Authors' Reply
Candice L. Clarke, Maria Prendecki, Stephen P. McAdoo, Michelle Willicombe
JASN Dec 2020, 31 (12) 2968; DOI: 10.1681/ASN.2020091276

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Authors' Reply
Candice L. Clarke, Maria Prendecki, Stephen P. McAdoo, Michelle Willicombe
JASN Dec 2020, 31 (12) 2968; DOI: 10.1681/ASN.2020091276
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Disclosures
    • Funding
    • Footnotes
    • References
  • Info & Metrics
  • View PDF

More in this TOC Section

  • On the Increased Event Rate of Urinary Tract Infection and Pneumonia in CKD Patients Treated with Roxadustat for Anemia
  • Authors’ Reply
  • Receptor-Mediated Endocytosis and Differentiation in Proximal Tubule Cell Systems
Show more Letters to the Editor

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Related Articles

  • Prevalence of COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening
  • PubMed
  • Google Scholar

Keywords

  • Seroprevalence
  • COVID-19

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe to ASN Journals

© 2021 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire